iSpecimen regains Nasdaq compliance on stockholders' equity, matter closed

iSpecimen Inc.

Received Nasdaq letter on Nov 28, 2025 confirming compliance with continued listing requirements.
Previously disclosed deficiency on June 4, 2025 for minimum equity, market value, or net income.
Based on Q3 2025 10-Q showing stockholders' equity of $3,072,711, Staff determined compliance and closed matter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.